Home›Stock Screener›Panacea Biotec›Intrinsic Value

Panacea Biotec Intrinsic Value

Panacea Biotec intrinsic value. Panacea Biotec (PANACEABIO) median intrinsic value is ₹705.70 from 8 valuation models (range ₹106–₹882), vs current price ₹352.85 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Analyse PANACEABIO FII DII holdings to track promoter, FII and institutional holdings.

Market Price (CMP)
₹352.85
Primary Intrinsic Value
₹167.20
Market Cap
₹211.7 Cr
+100.0% Upside
Median Value
₹705.70
Value Range
₹106 - ₹882
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

PANACEABIO Valuation Methods Summary — DCF, Graham Number & P/E

Panacea Biotec intrinsic value across 8 models vs current price ₹352.85 — upside/downside and value range per method. Browse PANACEABIO financial statements for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹167.20 ₹133.76 - ₹200.64 -52.6% EPS: ₹7.60, Sector P/E: 22x
Book Value Method asset ₹882.12 ₹793.91 - ₹970.33 +150.0% Book Value/Share: ₹1381.67, P/B: 2.0x
Revenue Multiple Method revenue ₹705.70 ₹635.13 - ₹776.27 +100.0% Revenue/Share: ₹1326.67, P/S: 2.0x
EBITDA Multiple Method earnings ₹705.70 ₹635.13 - ₹776.27 +100.0% EBITDA: ₹100.00Cr, EV/EBITDA: 10x
PEG Ratio Method growth ₹105.86 ₹95.27 - ₹116.45 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹117.42 ₹105.68 - ₹129.16 -66.7% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹705.70 ₹635.13 - ₹776.27 +100.0% ROE: 5.8%, P/E Multiple: 10x
Graham Defensive Method conservative ₹486.07 ₹437.46 - ₹534.68 +37.8% EPS: ₹7.60, BVPS: ₹1381.67
Method Types: Earnings Asset DCF Growth Dividend Conservative

PANACEABIO Intrinsic Value vs Market Price — All Valuation Models

Panacea Biotec fair value range ₹106–₹882 vs current market price ₹352.85 across 8 valuation models. For current market price and key ratios, visit Panacea Biotec share price screener.

PANACEABIO Intrinsic Value Analysis — Undervalued or Overvalued?

Panacea Biotec median intrinsic value ₹705.70, current price ₹352.85 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of PANACEABIO?

Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Panacea Biotec (PANACEABIO) is ₹705.70 (median value). With the current market price of ₹352.85, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹105.86 to ₹882.12, indicating ₹105.86 - ₹882.12.

Is PANACEABIO undervalued or overvalued?

Based on our multi-method analysis, Panacea Biotec (PANACEABIO) appears to be trading below calculated value by approximately 100.0%.

PANACEABIO Financial Health — Key Ratios vs Industry Benchmarks

Panacea Biotec financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 5.8% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 8.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.63x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

PANACEABIO Cash Flow Quality — Operating & Free Cash Flow

Panacea Biotec operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹17 Cr ₹-4 Cr Positive Operating Cash Flow 6/10
March 2025 ₹-27 Cr ₹-27 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹-423 Cr ₹-423 Cr Negative Cash Flow 3/10
March 2022 ₹-108 Cr ₹-108 Cr Negative Cash Flow 3/10